Flow Imaging Microscopy Analysis Industry Is Estimated To Witness High Growth Owing To Opportunity For Enhanced Drug Discovery And Quality Control Process In The Pharmaceutical Industry
Flow Imaging Microscopy Analysis Market
Flow Imaging Microscopy Analysis is an analytical technique used for particle characterization and counting using digital imaging. It provides high resolution digital images of biological and non-biological particles in liquid suspension for analysis. Flow imaging microscopy helps in improving quality control processes in various industries such as pharmaceutical, nutraceutical, and food by analyzing particulate contamination. Increasing R&D expenditure by pharmaceutical companies on drug discovery and quality control processes is driving the demand for flow imaging microscopy globally.
The global Flow Imaging Microscopy Analysis
Market is estimated to be valued at Us$
84 Million in 2023 and is expected to exhibit a CAGR Of 8.7% over the forecast period 2023-2031, as highlighted in a new report published by Coherent
Market Insights.
Market Opportunity:
The increasing adoption of flow imaging microscopy analysis in pharmaceutical
and biotechnology industry for enhanced drug discovery processes provides a
major growth opportunity for flow imaging microscopy analysis market. Flow
imaging microscopy helps in screening of potential drug candidates by analyzing
particulate properties such as size, shape, and texture. This improves
efficiency and success rate of drug development processes. With rising R&D
expenditure of pharmaceutical companies on development of novel drugs, the
demand for flow imaging microscopy is expected to significantly rise in the
coming years, driving the market growth.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate as manufacturing
requires high investment in R&D. However, large laboratory chains have
budgets for constant innovation and development of new methods.
Bargaining
power of buyers: Buyers have moderate bargaining power as there are several
established players in the flow imaging microscopy market providing
substitutable products. However, customized solutions require collaboration.
Bargaining
power of suppliers: Original equipment manufacturers and reagent suppliers have
low to moderate bargaining power due to the presence of alternate suppliers.
Threat
of new substitutes: The threat of substitutes is low as flow imaging microscopy
provides unmatched capabilities for high-resolution imaging of cells and
particles in suspension.
Competitive
rivalry: The competitive rivalry is high among established global players
continuously innovating to gain market share and collaborate with research
institutions.
SWOT Analysis
Strength: Flow imaging microscopy offers real-time, non-invasive analysis of
multiple parameters for each particle without labeling. It has applications in
bioprocessing, food & beverages, and healthcare research.
Weakness:
High costs of flow imaging microscopes limit their adoption to research and
large laboratories. Optimizing protocols requires expert training and support.
Opportunity:
Growing stem cell therapies and cell-based research present opportunities.
Collaboration with pharma companies can help address unmet need of verifying
cell identity.
Threats:
Budget cuts in research spending amid COVID-19 pandemic and economic downturn
pose challenges in commercialization. Stringent regulations in healthcare also
increase compliance costs.
Key Takeaways
The Global Flow Imaging Microscopy Analysis Market Demand
is expected to witness high growth
over the forecast period owing to increasing R&D investments in
biopharmaceutical and biotechnology sectors.
North
America dominates the market currently due to presence of major players and
strong government funding for life sciences research in the US. Europe exhibits
high demand for customized flow cell-based solutions in vaccine development and
manufacturing. Asia Pacific is expected fastest growth with increasing clinical
research in China, India, and Japan.
Key players operating in the flow imaging microscopy market are Bio-Rad
Laboratories, ProteinSimple, Fluid Imaging Technologies, Sysmex Corporation,
and OC Advanced Medical. Bio-Rad provides considerable product portfolio and
expertise in cell-based assays for immunology research. Sysmex invests heavily
in applying their technology to clinical applications like detecting cancer
cells in blood.
Get more insights on this topic :
Check more trending articles on this topic:
https://techaxen.com/mesenchymal-stem-cells-the-future-of-regenerative-medicine/
Comments
Post a Comment